Christopher A. Baker (@bakermind) 's Twitter Profile
Christopher A. Baker

@bakermind

Firstgen in Yale Center for Infection & Immunity using imaging technologies to alleviate pain in long COVID and similar syndromes. bakermind.bsky.social

ID: 877010317

calendar_today13-10-2012 03:56:38

7,7K Tweet

1,1K Followers

1,1K Following

I AM ALS (@iamalsorg) 's Twitter Profile Photo

Our friends at Paralyzed Veterans of America (Paralyzed Veterans of America (PVA)) are at the forefront of advocacy around preserving the VA’s system of care. Read their letter, which opposes dismantling the VA’s SCI/D system of care, and sign their petition: pva.org/news-and-media…

Our friends at Paralyzed Veterans of America (<a href="/PVA1946/">Paralyzed Veterans of America (PVA)</a>) are at the forefront of advocacy around preserving the VA’s system of care. Read their letter, which opposes dismantling the VA’s SCI/D system of care, and sign their petition: pva.org/news-and-media…
PolyBio (@polybiorf) 's Twitter Profile Photo

Heads up long COVID patients in the NYC area: We need more participants for this PolyBio-supported trial👇 The trial is testing if repurposed HIV medications (either Truvada or Maraviroc) reduce symptom burden in long COVID. Learn more here: polybio.org/projects/a-cli…

Hannah Davis (@ahandvanish) 's Twitter Profile Photo

People with COVID (non-hospitalized!) had significantly higher rates of bacterial, fungal, & viral infections. They were also 46% more likely to have outpatient respiratory infections & 41% more likely to be later hospitalized for infectious illnesses. thelancet.com/journals/lanin…

Mitsuaki Sawano, MD (@mitsuakisawano) 's Twitter Profile Photo

1/5 🔥 Hot off the press — PAXLC trial results now in The Lancet Infectious Diseases (🇯🇵日本語解説付き) After 3 years of dedicated work, we’re proud to share results from PAX LC: a fully decentralized, double-blind, placebo-controlled, FDA-authorized Phase 2 trial of Paxlovid

1/5 🔥 Hot off the press — PAXLC trial results now in <a href="/TheLancetInfDis/">The Lancet Infectious Diseases</a> (🇯🇵日本語解説付き)

After 3 years of dedicated work, we’re proud to share results from PAX LC: a fully decentralized, double-blind, placebo-controlled, FDA-authorized Phase 2 trial of Paxlovid
Michael R Scoma MD (@drscomame_cfs) 's Twitter Profile Photo

Three new patients this week, one severe, all with Long COVID following infections in January and February - all without a single issue prior. Long COVID is not going away and new cases are emerging. #LongCovidAwareness

Three new patients this week, one severe, all with Long COVID following infections in January and February - all without a single issue prior.  Long COVID is not going away and new cases are emerging. #LongCovidAwareness
Christopher A. Baker (@bakermind) 's Twitter Profile Photo

If New Haven is Avelo Airlines 's most important market, they might have shot themselves in the foot by signing up to conduct ICE deportation flights (and then blaming New Haven for their problems) nhregister.com/news/article/a…

Christopher A. Baker (@bakermind) 's Twitter Profile Photo

Nominations open for a prize for nanometer-scale connectomics, in honor of my friend Jennifer N. Bourne sfn.org/careers/awards…

Christopher A. Baker (@bakermind) 's Twitter Profile Photo

Has importing python packages been a major problem to making your code great? Now you can impose TARIFFS on whenever you import a package github.com/hxu296/tariff

Christopher A. Baker (@bakermind) 's Twitter Profile Photo

"COVID-19 has killed more Americans than all the wars in the 20th century combined" ~ Shane Crotty, La Jolla Institute for Immunology

C. Van Stappen (@ceeveeess1) 's Twitter Profile Photo

Hiring! **Please retweet** Looking for a postdoc to join my group at Indiana University Indiana University Chemistry Department! If you're interested in protein design, spectroscopy, catalysis and an open work environment, please send your CV, cover letter, and brief research summary to [email protected]

Christopher A. Baker (@bakermind) 's Twitter Profile Photo

This tower would have created construction jobs, science jobs, staff and admin jobs, and would have improved a city that has often struggled. Now it's postponed if not canceled. Thanks, Elon Musk ctmirror.org/2025/04/23/nih…

Christopher A. Baker (@bakermind) 's Twitter Profile Photo

I just want to thank Scott Galloway for this uplifting commentary on American universities as engines of innovation, as well as his recognition of PhDs as incredible contributors to society and human knowledge. Have a nice weekend youtu.be/r4N7BKtgJHo?t=…

Christopher A. Baker (@bakermind) 's Twitter Profile Photo

How do Tucker and Elon and Rogan feel about RFKjr tapping David Geier to research autism, given that he used to advocate treating autistic people with Lupron to lower testosterone in males?

nature (@nature) 's Twitter Profile Photo

Will US science survive Trump 2.0? In just the first three months of his second term, President Donald Trump has destabilized eight decades of government support for science. (🧵1/2)